Does Aurora Cannabis seem attractive after its earnings?

Is Aurora Cannabis attractive?

Aurora Cannabis (ACB) is one of the leading stocks of marijuana for investors. The company released its third quarter results on May 14. The company recorded sequential growth in its net business turnover of 20%, to $ 65 million, compared with $ 54 million in the previous quarter. Aurora Cannabis generated net income growth of $ 16.1 million or 305% year-over-year. The stock has changed slightly since its third quarter results. Aurora Cannabis closed at 11.7 Canadian dollars on May 14th. The ETFMG Alternative Harvest ETF (MJ) closed up 1.7% to $ 33.9. Let's see if the stock looks attractive according to its valuation.

Register for Bagels & Stox, our witty look at the news of the best markets and investments, right in your inbox! Whether you are a serious investor or just want to be informed, Bagels & Stox will be your favorite email.

Transmit several

Aurora Cannabis traded at a multiple of 14.2 times the sales to sales ratio, which was lower than its valuation multiple of 14.7 times before earnings. On May 15, the stock continued trading at a significant premium over its median multiple of 6.4x. The stock also traded above its historic multiple of 10.4x.

Canopy Growth (WEED) traded at a multiple of 22.0x, while the Cronos group (CRON) traded at a multiple of 25.3x. Tilray (TLRY) traded at a relatively lower multiple of 13.0x. Aphria (APHA) markets at a multiple of 3.1x. Compared to the above mentioned shares, Aphria experienced a negative sentiment after its profits. Aphria registered a write-off related to its acquisition in Latin America.